Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B
Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
On CNBC's "Mad Money Lightning Round," Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA).On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and an
Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.Shares of Seritage Growth Properties (NYSE:SRG) fell sharply in today's pre-market trading after
Express News | Mind Medicine (MindMed) Inc. : Oppenheimer Cuts Target Price to $20 From $29
Mind Medicine Is Maintained at Buy by HC Wainwright & Co.
Mind Medicine Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35
HC Wainwright & Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $75 to $35.
Mind Medicine Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 280.43% HC Wainwright & Co. $75 → $35 Maintains Buy 04/15/2024 117.39% Leerink Partners → $20 I
Express News | Mind Medicine (MindMed) Inc : H.c. Wainwright Cuts Target Price to $35 From $75
Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript Summary
The following is a summary of the Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript:Financial Performance:Mind Medicine raised approximately $175 million from an oversubscribed unde
Mind Medicine Presents New Studies At ISPOR 2024 Showing Growing Burden And Impact Of Generalized Anxiety Disorder In The U.S.
-GAD Diagnosis Increases Healthcare Costs and Decreases Work Productivity and Health-Related Quality of Life--People with Undiagnosed GAD Incur Even Higher Total Healthcare Costs than those Diagnosed
Mind Medicine Inc (MNMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Advances Amid ...
Mind Medicine Retained Executive Search Firm to Assist in Identifying a New CFO
Mind Medicine Retained Executive Search Firm to Assist in Identifying a New CFO
Mind Medicine Made Transition in CFO Role Resulting in Departure of Schond Greenway >MNMD
Mind Medicine Made Transition in CFO Role Resulting in Departure of Schond Greenway >MNMD
10-Q: Quarterly report
Express News | Mind Medicine (MindMed) Inc: On May 3, 2024, Company Made a Transition in Role of Chief Financial Officer Resulting in Departure of Schond Greenway
Express News | Mind Medicine (MindMed) Inc: Cash and Cash Equivalents of $252.3 Mln as of March 31, 2024
Express News | Mind Medicine Q1 2024 GAAP EPS $(1.14) Misses $(0.53) Estimate
Mind Medicine MindMed 1Q Loss/Shr $1.14 >MNMD
Mind Medicine MindMed 1Q Loss/Shr $1.14 >MNMD
Express News | MindMed Q1 Net Income USD -54.4 Million
Express News | MindMed Q1 Basic EPS USD -1.14